Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

B Cells of the Proliferative Fraction of CLL Clones Exhibit Activated B-Cell and Myeloid-Cell Signatures Suggesting Enhanced Antigen-Presentation, Integrin Responsiveness, and IL-4 Receptiveness: Additional Targets for CLL Therapy

Xiao-Jie Yan, MD PhD, Florencia Palacios, PhD, Wentian Li, PhD, Sophia Yancopoulos, PhD, Carlo Calissano, MD, Jacqueline C. Barrientos, MD, Steven L. Allen, MD, Jonathan E. Kolitz, MD, Kanti Rai, MD, Nicholas Chiorazzi, MD

Blood (2016) 128 (22): 302.

https://doi.org/10.1182/blood.V128.22.302.302

Published: 2016

Journal Articles

Gene Expression Profiles Document That Recently- and Previously-Divided CLL Fractions Represent a Continuum but Suggest Differing Modes of Activation for These Fractions in U-CLL and M-CLL

Xiao J. Yan, MD, PhD, Wentian Li, Ph.D., Sophia Yancopoulos, PhD, Igor Dozmorov, PhD, Carlo Calissano, MD, Sonia Marsilio, PhD, Rajendra N Damle, PhD, Steven L. Allen, MD, Jonathan E. Kolitz, MD, Jacqueline C. Barrientos, MD, Kanti R. Rai, M.D., Nicholas Chiorazzi, MD

Blood (2012) 120 (21): 317.

https://doi.org/10.1182/blood.V120.21.317.317

Published: 2012

Journal Articles

Longitudinal Analyses of CXCR4 dim CD5 br CD19 + Fractions of Chronic Lymphocytic Leukemia Clones Reveal Features Consistent with a Source of Clonal Heterogeneity

Rajendra N Damle, PhD, Carlo Calissano, MD, Sonal Temburni, MS, Ryon M. Andersen, B.A., Steven L. Allen, M.D., Jonathan E. Kolitz, MD, Kanti R. Rai, M.D., Nicholas Chiorazzi, M.D.

Blood (2011) 118 (21): 804.

https://doi.org/10.1182/blood.V118.21.804.804

Published: 2011

Journal Articles

Autologous Human T Cells and Allogeneic Antigen-Presenting Cells Permit Effective Adoptive Transfer of B-CLL Cells Into Immune Deficient Mice.

Davide Bagnara, PhD, Matthew Kaufman, MD, Carlo Calissano, MD, Sonia Marsilio, PhD, Philip Chum, Xiao J. Yan, MD, PhD, Peter K Gregersen, MD, Annette Lee, PhD, Kanti R Rai, MD, Nicholas Chiorazzi, MD

Blood (2009) 114 (22): 2326.

https://doi.org/10.1182/blood.V114.22.2326.2326

Published: 2009

Journal Articles

Multi-Parameter Phenotypic Analysis of Members of Chronic Lymphocytic Leukemia Clones Identifies Distinct Proliferative and Resting/Re-Entry Compartments with Discrete Gene Expression Profiles.

Carlo Calissano, MD, Rajendra N Damle, PhD, Xiao J. Yan, MD, PhD, Wentian Li, PhD, Sonia Marsilio, PhD, Jonathan E. Kolitz, MD, Matthew S. Kaufman, MD, Steven L Allen, MD, Kanti R. Rai, MD, Nicholas Chiorazzi, MD

Blood (2009) 114 (22): 668.

https://doi.org/10.1182/blood.V114.22.668.668

Published: 2009

Journal Articles

In Vivo Labeling of Dividing Chronic Lymphocytic Leukemia B Cells Suggests That CXCR4 and CD5 Define the Clonal Subfraction That Recently Proliferatead and Emigrated from a Solid Tissue

Carlo calissano, MD, Rajendra Damle, PhD, Gregory Hayes, PhD, Elisabeth J Murphy, MD, PhD, Marc Hellerstein, MD, PhD, Barbara Sherry, PhD, Matthew S Kaufman, MD, Steven L Allen, MD, Kanti Rai, MD, Nicholas Chiorazzi, MD

Blood (2008) 112 (11): 358.

https://doi.org/10.1182/blood.V112.11.358.358

Published: 2008

Journal Articles

Expression of CD38 and High Levels of CD5 Identifies Members of CLL Clones That Have Progressed beyond G1 and Proliferated.

Carlo Calissano, MD, Rajendra N. Damle, PhD, Marc Hellerstein, MD, Elisabeth J. Murphy, MD, Gregory M. Hayes, PhD, Kaufman Matthew, MD, Steven Allen, MD, Kanti Rai, MD, Nicholas Chiorazzi, MD

Blood (2007) 110 (11): 1114.

https://doi.org/10.1182/blood.V110.11.1114.1114

Published: 2007

Journal Articles

In Vivo Labeling of Newly Synthesized DNA Suggests That the CD38 + Fraction Is Enriched in Proliferating Cells within a Clone of Chronic Lymphocytic Leukemia B Cells.

Carlo Calissano, MD, Rajendra Damle, PhD, Taraneh Banapour, BS, Denise Cesar, Marc Hellerstein, MD, PhD, Steven Allen, MD, Kanti Rai, MD, Nicholas Chiorazzi, MD

Blood (2006) 108 (11): 27.

https://doi.org/10.1182/blood.V108.11.27.27

Published: 2006

NARROW

B Cells of the Proliferative Fraction of CLL Clones Exhibit Activated B-Cell and Myeloid-Cell Signatures Suggesting Enhanced Antigen-Presentation, Integrin Responsiveness, and IL-4 Receptiveness: Additional Targets for CLL Therapy

Gene Expression Profiles Document That Recently- and Previously-Divided CLL Fractions Represent a Continuum but Suggest Differing Modes of Activation for These Fractions in U-CLL and M-CLL

Longitudinal Analyses of CXCR4 dim CD5 br CD19 + Fractions of Chronic Lymphocytic Leukemia Clones Reveal Features Consistent with a Source of Clonal Heterogeneity

Autologous Human T Cells and Allogeneic Antigen-Presenting Cells Permit Effective Adoptive Transfer of B-CLL Cells Into Immune Deficient Mice.

Multi-Parameter Phenotypic Analysis of Members of Chronic Lymphocytic Leukemia Clones Identifies Distinct Proliferative and Resting/Re-Entry Compartments with Discrete Gene Expression Profiles.

In Vivo Labeling of Dividing Chronic Lymphocytic Leukemia B Cells Suggests That CXCR4 and CD5 Define the Clonal Subfraction That Recently Proliferatead and Emigrated from a Solid Tissue

Expression of CD38 and High Levels of CD5 Identifies Members of CLL Clones That Have Progressed beyond G1 and Proliferated.

In Vivo Labeling of Newly Synthesized DNA Suggests That the CD38 + Fraction Is Enriched in Proliferating Cells within a Clone of Chronic Lymphocytic Leukemia B Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only